Specific tariff entries prevail over generic descriptions when processing creates a distinct marketable product and Ayurvedic classification evidence is lacking

Processes such as mixing, filtering, packing and branding can amount to manufacture when they create commercially identifiable products distinct from the inputs; on that basis, Gulabari and Keora Water were held to fall under the specific tariff entries for Rose Water and Keora Water rather than the generic heading for aqueous solutions of essential oils. For Shilajit Capsules, the record did not establish manufacture in accordance with an authoritative Ayurvedic text, so the product was treated as patent and proprietary Ayurvedic medicine rather than a classical Ayurvedic preparation. Applying these classifications, the denial of exemption and the demand order were not sustainable, and the appeals succeeded with consequential relief.

---

---

Issues: (i) Whether the processes undertaken for Gulabari and Keora Water resulted in manufacture and whether those products were classifiable under the specific tariff headings for Rose Water and Keora Water instead of the generic heading for aqueous solutions of essential oils; (ii) Whether Shilajit Capsules were patent and proprietary Ayurvedic medicines or generic/classical Ayurvedic medicines so as to determine the availability of exemption.

Issue (i): Whether the processes undertaken for Gulabari and Keora Water resulted in manufacture and whether those products were classifiable under the specific tariff headings for Rose Water and Keora Water instead of the generic heading for aqueous solutions of essential oils.

Analysis: The processes involved mixing, filtering, packing, branding and other steps that brought into existence commercially identifiable products distinct from the inputs. The products were marketed and labelled as Rose Water and Keora Water, and the tariff specifically named them under the relevant headings. In the absence of any statutory definition to displace the ordinary commercial understanding, the specific entries had to prevail over the generic heading for aqueous solutions of essential oils.

Conclusion: The products were manufactured goods and were correctly classifiable under the specific tariff headings for Rose Water and Keora Water; the contrary classification was unsustainable.

Issue (ii): Whether Shilajit Capsules were patent and proprietary Ayurvedic medicines or generic/classical Ayurvedic medicines so as to determine the availability of exemption.

Analysis: The record did not show that the product was manufactured in accordance with any authoritative Ayurvedic text. The appellant had obtained drug licence support for its own formula, and the Department did not produce contrary documentary material to establish classification as a classical Ayurvedic medicine. On the material available, the product answered the description of a patent and proprietary Ayurvedic medicine.

Conclusion: Shilajit Capsules were not proved to be generic/classical Ayurvedic medicines and were to be treated as patent and proprietary Ayurvedic medicines.

Final Conclusion: The denial of exemption and the demand order could not be sustained, and the appeals succeeded with consequential relief.

Ratio Decidendi: Where a product is commercially identifiable by a specific tariff entry and the manufacturing process yields a distinct marketable product, the specific entry prevails over a generic residual description; a claim that an Ayurvedic product is classical must be supported by evidence that it is manufactured according to an authoritative text.

---